Loading
Latest filing published 26 Nov 2025 for Kairos Pharma, LTD.. Read the official filing
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
All filings by Ramachandran Murali on record concern Kairos Pharma, Ltd. We count 3 filings; the first trade dates from 25 November 2024 and the latest from 8 October 2025.
On the market, this insider has only ever bought: 1 purchase, €303 in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 2 share grants.
The newest entry dates from 26 November 2025: a share grant, in Kairos Pharma, Ltd. The last purchase on record was published on 25 November 2024, which is 692 days ago. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations